Top Posts All Search About Log in Wrld Global

Search

#Hypertension
Avatar
CBS News @cbsnews.com · New York 🇺🇸· 3w

#HeartHealth #HypertensionAwareness #PublicSafety

Link Preview
www.cbsnews.com
A police officer thought he had a muscle cramp. He ended up fighting for his life.
Kerry Breen is a news editor at CBSNews. com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital.
Avatar
Medscape @medscape.com · New York 🇺🇸· Jan 5

#Diabetes #Hypertension #CardiovascularHealth

Link Preview
www.medscape.com
Early Hypertension Linked to a Poorer Prognosis in T2D
In patients with type 2 diabetes (T2D), both young-onset hypertension (onset before the age of 45 years) and late-onset hypertension (onset at the age of 45 years or later) were associated with higher risks for cardiovascular disease (CVD), congestive heart failure, chronic kidney disease, and all-cause mortality, with young-onset hypertension linked to poorer outcomes.
S
StreetInsider.com @streetinsider.com · Jan 5

#Hypertension #Healthcare #Innovation

Link Preview
www.streetinsider.com
Idorsia's JERAYGO (aprocitentan) approved in Canada for the treatment of resistant hypertension
* Idorsia receives approval from Health Canada for JERAYGO (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.
B
Bloomberg Business @bloomberg.com · New York City 🇺🇸· Jan 5

#HealthTech #Hypertension #SmartDevices

Link Preview
www.bloomberg.com
Smart Scale Pioneer Debuts $600 Model That Tracks Hypertension Risk
The Body Scan 2 measures more than 60 biomarkers and notifies users that they're at risk of high blood pressure, rather than issuing a definitive diagnosis.
Avatar
Benzinga @benzinga.com · Detroit 🇺🇸· Jan 5

#Hypertension #HeartHealth #Pharmaceuticals

Link Preview
www.benzinga.com
Idorsia's JERAYGO (aprocitentan) approved in Canada for the treatment of resistant hypertension
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity NewsletterIdorsia receives approval from Health Canada for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.

Trends for you

#tariffs (161)
#supremecourt (137)
#tradepolicy (49)
#trump (45)
#olympics (58)
#economy (34)
#hockey (29)
#trumpadministration (21)
#teamusa (23)
#iran (32)

Who to follow

N
Novinykraje.cz
@novinykraje.cz
Avatar
Angela White (Parody)
@AngelaWhiteTwin
Avatar
Popsaný papír
@Lenkazacl